Dermata Therapeutics Inc. Gains 44%
Mon, Mar 21, 2022 at 05:30 PM
Dermata Therapeutics Inc. (DRMA:NASDAQ) soared at $1.44, a gain of 44%. On Fri, Mar 18, 2022, DRMA:NASDAQ hit a New 2-Week Intraday High of $1.12. From Mon, Mar 07, 2022, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Wed, Nov 03, 2021 at $6.95 with a volume of 4M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 299.36%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 58.44%
- Yumanity Therapeutics Inc. (YMTX:NASDAQ), 58.04%
- BitNile Holdings Inc. (NILE:NYSEMKT), 48.56%
- UTime Limited (UTME:NASDAQ), 44.79%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 44%
- CYREN Ltd. (CYRN:NASDAQ), 43.22%
- PainReform Ltd. (PRFX:NASDAQ), 39.64%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 38.02%
- O2Micro International Limited (OIIM:NASDAQ), 34.37%